Additional confirmation of possible C... - Fight Prostate Ca...

Fight Prostate Cancer

2,900 members1,134 posts

Additional confirmation of possible COVID-19 benefits for those on abiraterone - FDA-approved drugs , , , as potential COVID-19 treatments

cujoe profile image
0 Replies

Additional confirmation of possible COVID-19 benefits for those on abiraterone.

Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system

from the Abstract:

". . .To find more immediately available COVID-19 antivirals, we established a two-tier drug screening system that combines SARS-CoV-2 enzyme-linked immunosorbent assay and cell viability assay, and applied it to screen a library consisting 1528 FDA-approved drugs. Cetilistat (anti-pancreatic lipase), diiodohydroxyquinoline (anti-parasitic), abiraterone acetate (synthetic androstane steroid), and bexarotene (antineoplastic retinoid) exhibited potent in vitro anti-SARS-CoV-2 activity (EC50 1.13–2.01 μM). Bexarotene demonstrated the highest Cmax:EC50 ratio (1.69) which was higher than those of chloroquine, hydroxychloroquine, and ivermectin. These results demonstrated the efficacy of the two-tier screening system and identified potential COVID-19 treatments which can achieve effective levels if given by inhalation or systemically depending on their pharmacokinetics." (emphasis added)

sciencedirect.com/science/a...

Be Safe & Stay Well - Captain K9

Written by
cujoe profile image
cujoe
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Coronavirus (COVID-19) Supply Chain Update - FDA Statement - February 27, 2020

This post is an update to one posted about a month ago suggesting that the spread of the...
cujoe profile image

Challenges from the Increased Spread of COVID-19

How will the COVID-19 pandemic affect cancer treatment and research? The most recent article from...
marnieg46 profile image

A look at the next generation of Androgen Receptor therapies--AR Degraders/PROTACS

Greetings FPC members, Recently, Cujoe the K9 Wonder asked me if ARV-110 might deserve a post and I...
NPfisherman profile image

Continuing discussion of Adaptive Theory-- Why does early chemotherapy result in lower response rates to Lu-177 and immunotherapy??

Greetings FPC warriors, In the spirit of continuing cujoe's look at Adaptive Theory, I raise the...
NPfisherman profile image

Curcumin (Theracurmin) Improves Mild Cognitive Impairment and Memory - A Randomized Clinical Trial

 This is a remarkable study of the effects of a highly bioavailable form of Curcumin,...
MateoBeach profile image